Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 30, 2023. (Total: 221577Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 13 (of 13 Records)

Query Trace: DNA Damage and ALK[original query]
Evidence that the lung Adenocarcinoma EML4-ALK fusion gene is not caused by exposure to secondhand tobacco smoke during childhood.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Jul 23 (7): 1432-4.
Ryan Bríd M, Wang Yi, Jen Jin, Yi Eunhee S, Olivo-Marston Susan, Yang Ping, Harris Curtis
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Lung cancer (Amsterdam, Netherlands) 2016 Jun .
Malapelle Umberto, Morra Francesco, Ilardi Gennaro, Visconti Roberta, Merolla Francesco, Cerrato Aniello, Napolitano Virginia, Monaco Roberto, Guggino Gianluca, Monaco Guglielmo, Staibano Stefania, Troncone Giancarlo, Celetti Ange
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Nature communications 2016 Oct 7 13131.
Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients.
European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672.
Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 4 26 (14): 3649-3661.
Zhang Kai, Hong Xiaohua, Song Zhengbo, Xu Yu, Li Chengcheng, Wang Guoqiang, Zhang Yuzi, Zhao Xiaochen, Zhao Zhengyi, Zhao Jing, Huang Mengli, Huang Depei, Qi Chuang, Gao Chan, Cai Shangli, Gu Feifei, Hu Yue, Xu Chunwei, Wang Wenxian, Lou Zhenkun, Zhang Yong, Liu
Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report.
Thoracic cancer 2020 2 11 (4): 1094-1098.
Tang Yong, Li Yadan, Zhang Lei, Tong Guihui, Ou Zhu'an, Wang Zhuocai, Zhang Henghui, Qiao Guib
Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors.
Frontiers in pharmacology 2021 6 12 645862.
Wen Yang, Lin Anqi, Zhu Weiliang, Wei Ting, Luo Peng, Guo Linlang, Zhang Ji
DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer.
Frontiers in oncology 2021 10 11 708294.
Dai Jiawei, Jiang Minlin, He Kan, Wang Hao, Chen Peixin, Guo Haoyue, Zhao Wencheng, Lu Hui, He Yayi, Zhou Caic
Genomic features of Chinese small cell lung cancer.
BMC medical genomics 2022 May 15 (1): 117.
Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma.
Journal of Cancer 2022 4 13 (5): 1565-1572.
Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho
Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma.
Pathology, research and practice 2022 Jan 231 153761.
Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cancer 2022 Jun .
Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam
Childhood Exposure to Excess Ionizing Radiation Is Associated with Dose-Dependent Fusions as Molecular Drivers of Papillary Thyroid Cancer.
Clinical thyroidology 2023 3 34 (4): 161-164.
Klubo-Gwiezdzinska Joan
TOP